Alto Share Price

Alto Share Price

NYSE: ANRO | Small Cap | Healthcare
$25.97
+$1.05 (4.21%) Last updated on 19 Nov, 2026 | 01:28 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Alto Stock Performance

Open
$24.95
Prev. Close
$24.92
Circuit Range
N/A
Day Range
$24.95 - $27.72
Year Range
$12.72 - $37.16
Volume
65,575
Average Traded
$26.85

Alto Share Price Today

As of 19 November 2026, Alto Neuroscience Inc.'s share price is $25.97. The stock opened at $24.95, compared to its previous close of $24.92. During today's trading session, Alto Neuroscience Inc.'s share price traded between $24.95 and $27.72, with an average price of $26.34. Over the past 52 weeks, the stock has recorded a high of $37.16 and a low of $12.72. In terms of performance, Alto Neuroscience Inc.'s share price has risen by 29.33% over the last six months and is up 87.98% on a year-on-year basis.

Alto Share Price Chart

Line chart of the Alto price trend over the selected period. The price rose overall, ranging from 24.95 to 27.64, ending at 25.97.
$24.95$27.72
L
Show Current Price
H

Alto Stock Fundamentals & Key Indicators

Market Cap
$749.29M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.37
Revenue (TTM)
$0.00
Return On Equity (TTM)
-32.10%
Profit Margin
N/A
Debt to Equity
0.05
Quarterly Earnings Growth YoY
-55.25%

Alto Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$16.18-$26.24-$27.64-$25.12
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-62.18%-5.34%9.12%

Alto Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$0.00$0.00
Net Profit-$61.43-$63.24
Net Profit MarginN/AN/A
Income ChangeN/A-2.95%

Alto Balance Sheet

All figures in USD Million

Particulars20252024
Non Current Assets6.978.21
Current Assets177.72169.34
Total Assets184.69177.54
Non Current Liabilities22.2216.07
Current Liabilities11.3310.01
Total Liabilities33.5526.08
Shareholders' Equity151.14151.46

Alto Cash Flow

Annually

All figures in USD Million

Particulars20252024
Operating-51.77-47.42
Investing-0.02-2.08
Financing60.08135.69

About Alto

Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individual's neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-207, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.

Alto Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$22.80
$25.96
+15.71%
Oct 2026
$25.87
$22.43
-12.43%
Sep 2026
$36.02
$25.62
-29.32%
Aug 2026
$26.65
$36.25
+33.76%
Jul 2026
$26.29
$27.10
+2.57%
Jun 2026
$20.05
$26.42
+31.57%
May 2026
$25.26
$20.08
-22.02%
Apr 2026
$22.57
$25.75
+14.17%
Mar 2026
$19.16
$22.55
+15.19%
Feb 2026
$14.59
$19.58
+26.73%
Jan 2026
$17.57
$15.45
-13.32%
Dec 2025
$13.27
$17.82
+29.03%

Alto Share Price FAQs